Pancreatic Cancer Research

ResearcherCarol Davila University of Medicine and PharmacyActive in the last 2 years

Mihai Ciocîrlan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6363-0320; OpenAlex author ID A5091833703. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 trial · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v17.i1.98409↗
  2. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells10081856↗

Trials 1

  1. Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield? Principal investigator NCT03303352↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cătălina Vlăduţ · 2 shared papers, 2021–2025 · strength 0.39
  2. Vlad Herlea · 2 shared papers, 2021–2025 · strength 0.39
  3. Maria Dobre · 2 shared papers, 2021–2025 · strength 0.39
  4. Elena Milanesi · 2 shared papers, 2021–2025 · strength 0.39
  5. Daniel Vasile Balaban · 2 shared papers, 2021–2025 · strength 0.39
  6. Radu Cristian Poenaru · 1 shared paper, 2025 · strength 0.25
  7. Mihail Eugen Hinescu · 1 shared paper, 2025 · strength 0.25
  8. Gabriel Constantinescu · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.